Shore Haven Wealth Partners, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Shore Haven Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $197,483 - $256,398	-1,794 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$99.73 - $148.48 $1,495 - $2,227	-15 Reduced 0.83%	1,794 $247,000
Q3 2021 Oct 28, 2021	SELL	$98.85 - $138.91 $62,275 - $87,513	-630 Reduced 25.83%	1,809 $251,000
Q2 2021 Nov 18, 2021	BUY	$65.78 - $105.02 $160,437 - $256,143	2,439 New	2,439 $236,000
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $160,437 - $256,143	-2,439 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $33,957 - $48,627	-530 Reduced 17.85%	2,439 $167,000
Q4 2020 Feb 10, 2021	BUY	$65.07 - $98.24 $193,192 - $291,674	2,969 New	2,969 $255,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Shore Haven Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Shore Haven Wealth Partners, LLC with notifications on news.